相关实验视频
Updated: May 13, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
405
在患有慢性脏疾病的患者中,达尔贝波丁诱导的可逆性妇产
Randah Abdullah Dahlan1, Maram Khalid Sait1, Alaa Khalil Monjed2
1Department of Internal Medicine, King Abdullah Medical City, Mecca, Makkah Province, Saudi Arabia.
Case reports in nephrology
|April 15, 2025
概括
这项案例研究突出了治疗贫血的药物达比波丁与慢性病的成年患者发生妇产不适 (男性乳腺组织扩大) 之间的潜在联系.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 妇联是男性乳腺腺组织的良性增殖,在婴儿期和青春期常见,通常自发地消失.
- 成人发病的妇产不良需要对潜在原因进行评估,包括药物副作用.
- 慢性病 (CKD) 与荷尔蒙失衡有关,这可能会导致妇产不适.
研究的目的:
- 报告达伯丁的使用与患有慢性脏病的成年男性患有疼痛性妇科马斯蒂亚的发展之间存在新的关联.
- 讨论潜在的病理生理机制,将红色受精刺激剂 (ESA) 与CKD患者的妇产不全联系起来.
主要方法:
- 一个78岁的男性患有慢性病的病例介绍,他在开始服用 darbepoetin.poetin 后出现了妇联.
- 详细的临床评估,以排除其他导致妇产不良的原因.
- 观察在达比波丁停止后的妇科复苏和在重新引入后的复发.
主要成果:
- 患者患上了与达比波使用暂时相关的疼痛性妇联.
- 药物停用后的妇科瘤消失,并在重新服用时复发,这表明存在因果关系.
- 尽管进行了广泛的评估,但没有发现其他可识别的妇产不良的原因.
结论:
- 达尔贝波丁可能会诱导成年CKD患者的妇产不全,这是以前未被描述的关联.
- 需要进行进一步的研究,以阐明合成红色素形成刺激剂可能影响激素调节并导致妇产不良的激素机制.
更多相关视频
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
8.3K
10:25Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
1.7K
相关概念视频
01:11Renal Failure: Dose Adjustments
37
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
321
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321
01:33Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
01:22Heart Failure Drugs: Diuretics
294
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
294
01:17Factors Affecting Renal Clearance: Renal Impairment
35
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
35
01:27Dialysis
231
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
231